Product Information
CLONAZEPAM 0.5 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0199 per EA under NDC 43547040611. Its NADAC has been published 426 times since May 2, 2018.
Strength
.5 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547040611
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077856On Market Since
2/15/2018
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 0.5 MG TABLET has been published 426 times since May 2, 2018, and over the history we have for it it has risen 23.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0199 per EA |
|---|---|
| All-time high | $0.0302 (Jul 12, 2023) |
| All-time low | $0.0162 (May 23, 2018) |
| 52-week high | $0.0224 |
| 52-week low | $0.0198 |
| Median price | $0.0248 |
| Average price | $0.0236 |
| Largest weekly change | -34.1% (Nov 20, 2024) |
| Weeks tracked | 426 |
| Tracking since | May 2, 2018 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLONAZEPAM 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 0.5 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0199 per EA (NDC 43547040611), effective Jun 24, 2026.
How has the price of CLONAZEPAM 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 0.5 MG TABLET has risen 23.0%. It has been tracked across 426 weekly CMS publications since May 2, 2018.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 0.5 MG TABLET?
Since May 2, 2018, the NADAC for CLONAZEPAM 0.5 MG TABLET has ranged from a low of $0.0162 (May 23, 2018) to a high of $0.0302 (Jul 12, 2023), with a median of $0.0248 per EA.
Are there cheaper alternatives to CLONAZEPAM 0.5 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as CLONAZEPAM 0.5 MG TABLET, but none are currently priced below it.
Who manufactures CLONAZEPAM 0.5 MG TABLET?
CLONAZEPAM 0.5 MG TABLET (NDC 43547040611) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification